Trademark Overview
On Wednesday, November 15, 2023, a trademark application was filed for NRIV with the United States Patent and Trademark Office. The USPTO has given the NRIV trademark a serial number of 98272144. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, November 18, 2023. This trademark is owned by Chromadex, Inc.. The NRIV trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations, namely, nicotinamide riboside for injection; pharmaceutical preparations, namely, injectable liquids for use in hydration, vitamin, healthy aging, and wellness therapies; pharmaceutical preparations, namely, injectable liquids for increasing health, healthy aging, cellular health, cellular repair, energy, heart health, and muscle health; nicotinamide riboside in the form of injectables; nicotinamide riboside for use in intravenous therapy; dietary supplements; nutritional supplements
On-line retail store services featuring injectables, intravenous solutions, dietary supplements, and nutritional supplements; retail store services featuring injectables, intravenous solutions, dietary supplements, and nutritional supplements
Intravenous therapy services; intravenous therapy services featuring nicotinamide riboside; providing information about health, healthy aging, lifestyle wellness, healthy eating, and nutrition